A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

(2014) Daniela Tacke et al.   ANNALS OF HEMATOLOGY

Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study

(2014) N. Lerolle et al.   CLINICAL MICROBIOLOGY AND INFECTION

Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients

(2014) Maria J. G. T. Vehreschild et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study

(2014) David Nachbaur et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Our 2014 approach to breakthrough invasive fungal infections

(2014) Georg Maschmeyer et al.   MYCOSES

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study

(2014) Hsiang-Chi Kung et al.   Cancer Medicine

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

(2013) Sabine Mousset et al.   ANNALS OF HEMATOLOGY

Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry

(2012) L. Pagano et al.   CLINICAL INFECTIOUS DISEASES

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study

(2012) J. Auberger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients

(2010) Drew J. Winston et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

(2010) J. J. Vehreschild et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species

(2009) P. A. Mann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

(2008) Jutta Auberger et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY